Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 4/20 | 0.36 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.36 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9868394 | 0.94 | CYP19A1 (0.50) | CYP19A1CYP11B1NOTUMMAPK1ALDH1A1 | |
| SCHEMBL3285588 | 0.85 | CYP19A1 (0.42) | CYP19A1CYP11B1MAPK1ALDH1A1TDP1 | |
| Oxalic Acid SCHEMBL9525556 | 0.81 | CYP19A1 (0.46) | CYP19A1CYP11B1NOTUMMAPK1KEAP1 | |
| Oxalic Acid SCHEMBL9523637 | 0.80 | CYP19A1 (0.76) | CYP19A1CYP11B1CYP3A4CYP11B2CYP2C19 | |
| Oxalic Acid SCHEMBL27267165 | 0.80 | CYP19A1 (0.76) | CYP19A1CYP11B1CYP3A4CYP11B2CYP2C19 | |
| SCHEMBL2352227 | 0.73 | CYP19A1 (0.58) | CYP19A1CYP11B1MAPK1ALDH1A1TDP1 | |
| Oxalic Acid SCHEMBL9524290 | 0.72 | CYP19A1 (0.47) | CYP19A1CYP11B1MAPK1ALDH1A1TDP1 | |
| Oxalic Acid SCHEMBL9524494 | 0.71 | CYP19A1 (0.72) | CYP19A1CYP11B1KEAP1RAB9A | |
| SCHEMBL9525014 | 0.71 | KEAP1 (0.50) | CYP19A1CYP11B1NOTUMMAPK1KEAP1 | |
| Oxalic Acid SCHEMBL9867754 | 0.70 | CYP19A1 (0.46) | CYP19A1CYP11B1MAPK1ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0293978-B1 | (1H-AZOL-1-YLMETHYL)SUBSTITUTED BENZOTRIAZOLE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-09-15 | — | — | EP | disclosed |
| US-4943574-A | AROMATASE INHIBITORS, ESTROGEN DISORDERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-07-24 | — | — | US | disclosed |
| EP-0293978-A2 | (1H-azol-1-ylmethyl)substituted benzotriazole derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1988-12-07 | — | — | EP | disclosed |